Methods to individualize combination therapy

Details for Australian Patent Application No. 2004227401 (hide)

Owner Celator Pharmaceuticals, Inc.

Inventors Mayer, Lawrence; Bally, Marcel; Janoff, Andrew S.

Agent Shelston IP

Pub. Number AU-A-2004227401

PCT Pub. Number WO2004/090537

Priority 60/495,394 15.08.03 US; 60/460,223 02.04.03 US; 60/496,180 18.08.03 US

Filing date 2 April 2004

Wipo publication date 21 October 2004

International Classifications

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/090537 Priority application(s): WO2004/090537

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227405-MtHP promoter element

2004227392-Identification of novel nogo-receptors and methods related thereto